13-cis-Retinoic acid in the treatment of recurrent glioblastoma multiforme

Authors:

Abstract
Basic science and clinical investigations have demonstrated that 13-cis-retinoic acid (cRA) has activity against malignant gliomas. To assess its eff

This publication has 21 references indexed in Scilit: